Kahn Clare has filed 5 insider transactions across 2 companies since June 2024.
Most recent transaction: a grant/award of 30782 shares of Stoke Therapeutics, Inc. ($STOK) on April 03, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 3, 2026 | Stoke Therapeutics, Inc. | $STOK | Kahn Clare | Not found | A | Stock Option (Right to Buy) | 30782 | $0.00 | 30,782.0000 | 60,397,681 | 9999.99% | 0.05% |
| June 12, 2025 | Solid Biosciences Inc. | $SLDB | Kahn Clare | Not found | A | Director Stock Option (Right to Buy) | 77500 | $0.00 | 77,500.0000 | 40,816,694 | 9999.99% | 0.19% |
| March 11, 2025 | Solid Biosciences Inc. | $SLDB | Kahn Clare | Not found | P | Common Stock | 1860 | $5.34 | 2,960.0000 | 40,816,694 | 169.09% | 0.00% |
| June 11, 2024 | Solid Biosciences Inc. | $SLDB | Kahn Clare | Not found | A | Director Stock Option (Right to Buy) | 34400 | $0.00 | 34,400.0000 | 19,884,007 | 9999.99% | 0.17% |
| June 7, 2024 | Solid Biosciences Inc. | $SLDB | Kahn Clare | Not found | P | Common Stock | 1100 | $7.67 | 1,100.0000 | 19,884,007 | 9999.99% | 0.01% |